| Pharmaceutical active ingredients: |
| Benserazide HydrochlorideLevodopa |
| Available forms, composition and doses of Madopar: |
| Capsules; Oral; Levodopa 100 mg; Benserazide Hydrochloride 25 mgCapsules; Oral; Levodopa 200 mg; Benserazide Hydrochloride 50 mgCapsules; Oral; Levodopa 50 mg; Benserazide Hydrochloride 12.5 mgTablets, Dispersible; Oral; Levodopa 100 mg; Benserazide Hydrochloride 25 mgTablets; Oral; Levodopa 100 mg; Benserazide Hydrochloride 25 mgTablets; Oral; Levodopa 200 mg; Benserazide Hydrochloride 50 mg |
| Madopar medical category: |
| Human:Antiparkinsonian drugsMiscellaneous central nervous system agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA02 - Levodopa and decarboxylase inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheDKSHFirma Chun CheongZentivaZuellig Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Leparson | Benserazide Hydrochloride; Levodopa | Dexa Medica Pharm & Chem |
| Levazide | Benserazide Hydrochloride; Levodopa | Pyridam |
| Levobens | Benserazide Hydrochloride; Levodopa | Viatris |
| Levodopa Comp. B | Benserazide Hydrochloride; Levodopa | Stada |
| Levopar Plus | Benserazide Hydrochloride; Levodopa | Teva |
| Madopar CR | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar Depot | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar Dispersible | Benserazide Hydrochloride; Levodopa | Roche; DKSH; Firma Chun Cheong; Zentiva |
| Madopar DR | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar Dual Release | Benserazide Hydrochloride; Levodopa | Roche |